Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
CALL
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $1.75M | ﹤0.01% |
17,600
+1,800
| +11% | +$177K |
|
|
INFN
3752
DELISTED
Infinera Corporation Common Stock
INFN
| $1.75M | ﹤0.01% |
194,194
-469,388
| -71% | -$4.54M |
|
3753
PUT
Brunswick
BC
$4.97B
| $1.75M | ﹤0.01% |
35,900
-110,500
| -75% | -$5.28M |
|
3754
PUT
Deluxe
DLX
$1.08B
| $1.75M | ﹤0.01% |
26,200
+3,200
| +14% | +$218K |
|
3755
CALL
Universal Insurance Holdings
UVE
$1.21B
| $1.75M | ﹤0.01% |
69,500
+35,000
| +101% | +$785K |
|
3756
CALL
Avery Dennison
AVY
$13.5B
| $1.75M | ﹤0.01% |
22,500
+1,000
| +5% | +$76.4K |
|
3757
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.39B
| $1.75M | ﹤0.01% |
35,139
-40,631
| -54% | -$1.98M |
|
|
ECHO
3758
CALL
EchoStar
ECHO
$25.2B
| $1.75M | ﹤0.01% |
+49,237
| New | +$1.56M |
|
|
BCR
3759
PUT
DELISTED
CR Bard Inc.
BCR
| $1.75M | ﹤0.01% |
7,800
+4,300
| +123% | +$968K |
|
3760
CALL
Enovis
ENOV
$1.44B
| $1.75M | ﹤0.01% |
32,304
+15,397
| +91% | +$776K |
|
3761
CALL
ProShares Short S&P500
SH
$826M
| $1.75M | ﹤0.01% |
11,475
+7,950
| +226% | +$1.22M |
|
3762
Invesco Dorsey Wright Energy Momentum ETF
PXI
$54.2M
| $1.75M | ﹤0.01% |
42,032
+20,347
| +94% | +$790K |
|
|
MSCC
3763
PUT
DELISTED
Microsemi Corp
MSCC
| $1.75M | ﹤0.01% |
41,600
+6,300
| +18% | +$241K |
|
3764
CALL
Banco Macro
BMA
$4.86B
| $1.75M | ﹤0.01% |
22,300
-36,000
| -62% | -$2.74M |
|
3765
PJT Partners
PJT
$4.67B
| $1.75M | ﹤0.01% |
63,998
+29,633
| +86% | +$742K |
|
3766
The Greenbrier Companies
GBX
$1.42B
| $1.74M | ﹤0.01% |
49,380
-60,254
| -55% | -$1.97M |
|
3767
CALL
SS&C Technologies
SSNC
$19.6B
| $1.74M | ﹤0.01% |
54,200
-106,000
| -66% | -$3.36M |
|
|
CEQP
3768
DELISTED
Crestwood Equity Partners LP
CEQP
| $1.74M | ﹤0.01% |
82,038
+2,728
| +3% | +$56.9K |
|
|
AGEN
3769
PUT
Agenus
AGEN
$345M
| $1.74M | ﹤0.01% |
12,360
+8,620
| +230% | +$988K |
|
|
ORBK
3770
CALL
DELISTED
Orbotech Ltd
ORBK
| $1.74M | ﹤0.01% |
58,800
+41,600
| +242% | +$1.18M |
|
3771
Helix Energy Solutions
HLX
$1.49B
| $1.74M | ﹤0.01% |
214,060
-37,967
| -15% | -$287K |
|
|
AKRX
3772
DELISTED
Akorn Inc
AKRX
| $1.74M | ﹤0.01% |
+63,828
| New | +$1.89M |
|
|
CVSA
3773
Covista Inc
CVSA
$4.58B
| $1.74M | ﹤0.01% |
75,405
| – | – |
|
|
XLPS
3774
DELISTED
POWERSHARES S&P SMALLCAP CONSUMER STAPLES PORT
XLPS
| $1.74M | ﹤0.01% |
26,521
+19,751
| +292% | +$1.3M |
|
3775
CALL
iShares S&P 500 Value ETF
IVE
$50.2B
| $1.74M | ﹤0.01% |
18,300
-1,600
| -8% | -$152K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.